Cited by 72Substance Abuse Treatment and OutcomesHealth Systems, Economic Evaluations, Quality of LifeOpioid Use Disorder Treatment

DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP)

Open access
Roebuck, M.Christopher, French, Michael T., McLellan, A.Thomas·2003·Journal of Substance Abuse Treatment

Abstract

The Drug Abuse Treatment Cost Analysis Program (DATCAP) was developed and launched in the early 1990s to help addiction researchers and administrators estimate the economic costs of substance abuse interventions. This paper presents summary results from 85 DATCAPs completed over the past 10 years. After first grouping the DATCAPs into 9 treatment modalities, cost measures (normalized to 2001 dollars) are reported along with client caseload information. Additionally, the distribution of costs across 6 resource categories is presented for each of the treatment modalities. The average weekly economic cost per client ranged from 82 US dollars per week for outpatient drug court interventions to 1,138 US dollars per week for adolescent residential treatment. As expected, labor was overwhelmingly the most utilized resource across all modalities, ranging from 48% to 88% of total economic cost. Addiction researchers, program administrators, and policymakers now have cost estimates and resource distribution information for various treatment modalities serving diverse populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0740-5472(03)00067-9

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Roebuck, French, and McLellan (2003) published the first summary article of all DATCAP studies to date, which amounted to 85 substance abuse treatment programs across 9 modalities.

    “Roebuck, French, and McLellan (2003) published the first summary article of all DATCAP studies to date, which amounted to 85 substance abuse treatment programs across 9 modalities.”

    From The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement (2008) · cites this paper as Roebuck, French, and McLellan (2003)

    The Discussion (page not provided) calls this a summary article and says it assembled 85 treatment programs into 9 modalities. The Introduction and Data management section (pages not provided) describe the 85 DATCAPs as work completed by the authors and their colleagues; our copy does not establish that this was the first summary article or that it covered all DATCAP studies to date. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 17 · Cited by 72

Research works printed but not linked: 16

  1. Barnett, P. G., Zaric, G. S., & Brandeau, M. L. (2001). The cost-effective- ness of buprenorphine maintenance therapy for opiate addiction in the US. Addiction, 96 (9), 1267 -1278.
  2. Bradley, C. J., French, M. T., & Rachal, J. V. (1994). Financing and cost of standard and enhanced methadone treatment. Journal of Substance Abuse Treatment, 11 (5), 433 -442.
  3. Bray, J. W., French, M. T., Bowland, B. J., & Dunlap, L. J. (1996). The cost of Employee Assistance Programs (EAPs): findings from seven case studies. Employee Assistance Quarterly, 11 (4), 1 -19.
  4. Drummond, M. F., O'Brien, C. P., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health care pro- grammes. New York: Oxford University Press.
  5. French, M. T. (2000). Economic evaluation of alcohol treatment services. Evaluation and Program Planning, 23 (1), 27 -39.
  6. French, M. T. (2002a). Drug Abuse Treatment Cost Analysis Program (DATCAP): Program version (8th ed.). Coral Gables: University of Miami (Available at www.DATCAP.com).
  7. French, M. T. (2002b). Drug Abuse Treatment Cost Analysis Program (DATCAP): User's manual (8th ed.). Coral Gables: University of Miami (Available at www.DATCAP.com).
  8. French, M. T., Dunlap, L. J., Zarkin, G. A., McGeary, K. A., & McLellan, A. T. (1997). A structured instrument for estimating the economic cost of drug abuse treatment: the Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment, 14 (5), 445 -455.
  9. French, M. T., Roebuck, M. C., McLellan, A. T., & Sindelar, J. L. (2001). Can the Treatment Services Review (TSR) be used to estimate the costs of addiction and ancillary services. Journal of Substance Abuse, 12 (4), 341 -361.
  10. French, M. T., Salome ´, H. J., Sindelar, J. L., & McLellan, A. T. (2002). Benefit-cost analysis of addiction treatment: methodological guidelines and application using the DATCAP and ASI. Health Services Research, 37 (2), 433 -455.
  11. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost- effectiveness in health and medicine. New York: Oxford University Press.
  12. Hargraeves, W. A., Shumway, M. T., Hu, W., & Cuffel, B. (1998). Cost- outcome methods for mental health. San Diego, CA: Academic Press.
  13. Kenkel, D. (1997). On valuing morbidity, cost-effectiveness analysis, and being rude. Journal of Health Economics, 16, 749 -757.
  14. Salome ´, H. J., & French, M. T. (2001). Using cost and financing instru- ments for economic evaluation of substance abuse treatment services. In M. Galanter (Ed.), Recent Developments in Alcoholism, Volume 15: Services Research in the Era of Managed Care ( pp. 253 -269). New York: Kluwer Academic/Plenum Publishers (Section III, Chapter 11).
  15. Salome ´, H. J., French, M. T., Miller, M., & McLellan, A. T. (in press). Estimating the client costs of addiction treatment: First findings from the Client Drug Abuse Treatment Cost Analysis Program (Client DAT- CAP). Drug and Alcohol Dependence.
  16. Zarkin, G. A., Lindrooth, R. C., Demiralp, B., & Wechsberg, W. (2001). The cost and cost-effectiveness of an enhanced intervention for peo- ple with substance abuse problems at risk for HIV. Health Services Research, 36 (2), 335 -356.

Authors
Roebuck, M. C., French, M. T., & McLellan, A. T.
Affiliations
  • University of Miami (US)
  • Treatment Research Institute (US)
Corresponding author
French, Michael T.
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
2003-07
Volume
25
Issue
1
Pages
51-57
ISSN
0740-5472 (ISSN-L)
OpenAlex
W2086274407
Cited by
72
References
17
Citations by year
2026: 2 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
3.76
Type
journal article
Language
en
Open access
Locations
  • Journal of Substance Abuse Treatment (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health and Human Services
  • National Institute on Alcohol Abuse and Alcoholism (R01AA013167, R01 AA 13167)
  • National Institute on Drug Abuse (R01DA11506, P50-DA07705, P50DA007705, R01DA011506)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
treatment options, labor costs, resource allocation
MeSH terms
Adolescent, Adult, Ambulatory Care, Costs and Cost Analysis, Data Collection, Health Resources, Humans, Length of Stay, Long-Term Care, Managed Care Programs, Mathematical Computing, Patient Care Team, Residential Treatment, Software, United States, Databases, Factual, Health Care Costs, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review